Clinical Trial Update: A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating onset of effect and time course of lung function change with benralizumab in severe eosinophilic asthma; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-10-07